Loss of human arylamine N-acetyltransferase I regulates mitochondrial function by inhibition of the pyruvate dehydrogenase complex-Reference-Cited by-同舟云学术

Loss of human arylamine N-acetyltransferase I regulates mitochondrial function by inhibition of the pyruvate dehydrogenase complex

Published:2019-05 Issue: Volume:110 Page:84-90
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Wang Lili,Minchin Rodney F.^ORCID,Essebier Patricia J.,Butcher Neville J.

Funder

the National Health and Medical Research Council of Australia

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference24 articles.

1. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells;Butcher;Cancer Res.,2007

2. Regulation of arylamine N-acetyltransferases;Butcher;Curr. Drug Metab.,2008

3. Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice;Camporez;Proc. Natl. Acad. Sci. U. S. A.,2017

4. Retrospective analysis of estrogen receptor 1 and Nacetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines;Carlisle;Int. J. Oncol.,2018

5. Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine N-acetyltransferase 1;Carlisle;Metabolomics,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration;ACS Pharmacology & Translational Science;2024-07-17

2. Function and expression of N-acetyltransferases 1 and 2 are altered in lymphocytes in type 2 diabetes and obesity;Biochemistry and Biophysics Reports;2024-07

3. Arylamine N-Acetyltransferases;Reference Module in Biomedical Sciences;2024

4. The arylamine N-acetyltransferases as therapeutic targets in metabolic diseases associated with mitochondrial dysfunction.;Pharmacological Reviews;2023-12-07

5. CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics;Frontiers in Molecular Biosciences;2023-07-04